← Back to Search

Opioid Analgesic

Tonsillectomy and Dilaudid + Tylenol for Postoperative Pain

Phase 4
Waitlist Available
Led By Samuel Pate, M.D.
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up preoperative weight compared to postoperative weight at 2-3 weeks after surgery
Awards & highlights

Study Summary

This trial will help doctors determine the best post-tonsillectomy pain medication regimen to minimize pain and help patients have a quicker recovery.

Eligible Conditions
  • Postoperative Pain
  • Postoperative Nausea and Vomiting
  • Postoperative Hemorrhage
  • Weight Changes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~preoperative weight compared to postoperative weight at 2-3 weeks after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and preoperative weight compared to postoperative weight at 2-3 weeks after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Daily pain level
Secondary outcome measures
Daily nausea/vomiting
Daily oral liquid intake
Post tonsillectomy hemorrhage
+2 more

Trial Design

3Treatment groups
Active Control
Group I: Tonsillectomy and Dilaudid + TylenolActive Control2 Interventions
This represents patients who will be randomized (1:3 chance) to postoperative pain control with Dilaudid (hydromorphone) and Tylenol (Acetaminophen)
Group II: Tonsillectomy and PercocetActive Control1 Intervention
This represents patients who will be randomized (1:3 chance) to postoperative pain control with Percocet (Oxycodone and Acetaminophen)
Group III: Tonsillectomy and NorcoActive Control1 Intervention
This represents patients who will be randomized (1:3 chance) to postoperative pain control with Norco (Hydrocodone and Acetaminophen)

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,707 Total Patients Enrolled
Samuel Pate, M.D.Principal InvestigatorUniversity of Nebraska Medical Center Department of Otolaryngology - Head and Neck Surgery

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies for volunteers in this experiment?

"According to information on clinicaltrials.gov, this medical project is not currently open for recruitment as the most recent update was made in October 2017. However, there are a plethora of other studies that require participants at present."

Answered by AI

To what ailments is the combination of Tonsillectomy, Dilaudid and Tylenol commonly recommended?

"Tonsillectomy and the combination of Dilaudid with Tylenol are both effective treatments for ailments such as catarrh, rhinorrhoea, and musculoskeletal pain."

Answered by AI

Has there been any additional research conducted on the combination of Tonsillectomy and Dilaudid plus Tylenol?

"Currently, there are 114 clinical trials underway for Tonsillectomy and Dilaudid + Tylenol. Out of these active studies, 32 have entered phase 3. Although the majority take place in Boston, Massachusetts, 1033 locations throughout the nation offer this treatment option to patients."

Answered by AI

What is the uppermost capacity of patients allowed to join this medical experiment?

"This study has ceased patient search as of October 18th, 2017. If you are seeking other trials to take part in, 1087 studies related to postoperative hemorrhage and 114 involving Tonsillectomy and Dilaudid + Tylenol are presently recruiting patients."

Answered by AI

Has the FDA authorized Tonsillectomy and Dilaudid + Tylenol for use?

"Our team at Power assigned a 3 out of 3 rating to the safety profile for Tonsillectomy and Dilaudid + Tylenol, as this is an approved Phase 4 trial."

Answered by AI
Recent research and studies
~3 spots leftby Apr 2025